When Global Policy Agendas Collide – Evidence, Value, and Pricing Tensions at the Intersection of EU and US Reform

About this session

Issue: Market access strategy is being reshaped by evolution of EU and US policy reforms that place competing emphasis on evidence generation and pricing. EU Joint Clinical Assessment (JCA) increases the need for robust, standardized comparative evidence that withstands scrutiny across Member States. Emerging US pricing policies threaten to link some US prices to lower international benchmarks.

Speakers

• OS

  Oliver Staples

  Moderator

• AT

  Aodan Tynan

  Panelist

• 

  Niklas Hedberg

  TLV

  Panelist

• 

  Duane Schulthess

  VitalTransformation BVBA

  Panelist